Page last updated: 2024-10-24

carmustine and Astroblastoma

carmustine has been researched along with Astroblastoma in 2 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Autran, D1
Barrie, M1
Matta, M1
Monserrat, C1
Campello, C1
Petrirena, G1
Boucard, C1
Padovani, L1
Loundou, A1
Appay, R1
Graillon, T1
Dufour, H1
Figarella-Branger, D1
Chinot, O1
Tabouret, E1
Kong, DS1
Kim, ST1
Lee, JI1
Suh, YL1
Lim, DH1
Kim, WS1
Kwon, KH1
Park, K1
Kim, JH1
Nam, DH1

Trials

1 trial available for carmustine and Astroblastoma

ArticleYear
Impact of adjuvant chemotherapy for gliomatosis cerebri.
    BMC cancer, 2010, Aug-13, Volume: 10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine

2010

Other Studies

1 other study available for carmustine and Astroblastoma

ArticleYear
Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients.
    Anticancer research, 2019, Volume: 39, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Combined M

2019